# Akso Health Group

Akso Health Group is an Asset Manager based in Qingdao, China.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Qingdao, China
- **Region:** Asia
- **Address:** Qingdao, Shandong, China
- **Assets under management:** Undisclosed
- **Website:** aksohealth.com

## Regulatory record

- **Reports private funds:** No

## About

Akso Health Group currently operates in a state of public but opaque transition. The company was originally founded as Hexindai, a Chinese peer-to-peer consumer lending business that debuted on NASDAQ in 2017. By 2019, tighter regulatory scrutiny on China's P2P sector forced a wholesale strategic pivot, with the core lending operations winding down and a rebrand to Akso Health taking effect in August 2020. The transition connects directly to Yilin Wang, who assumed the CEO role at the start of this restructuring period. The company nominally points toward digital health and hospital-service investments, but published financial filings indicate minimal operating revenue and a balance sheet largely held in cash and short-term instruments. Akso's post-pivot investment strategy remains opaque — no named portfolio companies, healthcare assets, or joint ventures appear in recent SEC submissions. The firm's disclosures reference a plan to seek health-sector acquisitions, yet no completed acquisitions have been publicly announced under the new mandate. Scale is difficult to assess. As a publicly traded entity, Akso reports limited headcount and volatile cash reserves, with no known institutional co-investors or notable fund structures launched. The absence of a disclosed pipeline, specific healthcare verticals, or named operating partners makes the current investment posture hard to differentiate from a public shell waiting on its next defining transaction. Structurally, Akso Health Group represents a publicly listed legacy entity reorienting by necessity rather than by built competency. The survivor-founders and management layer are navigating a thin transition that differs from venture-backed insurtech roll-ups or family-funded hospital groups — it is a public company with a history in marketplace lending, not a seasoned healthcare investor, and that factor shapes every decision a potential counterparty would make.

## Sectors

- Digital Health
- Healthcare Services
- FinTech

## People

- Yilin Wang — Chief Executive Officer

## Questions

### What was Akso Health Group before the rebrand?

Akso Health Group traded as Hexindai, a Chinese peer-to-peer consumer lending platform that went public on NASDAQ in 2017. The company discontinued its legacy lending operations following China's regulatory crackdown on P2P platforms in 2019 and 2020, and officially changed its corporate identity and ticker in August 2020.

### Does Akso Health Group have any known healthcare investments or portfolio companies?

No specific healthcare acquisitions, joint ventures, or direct investments have been publicly disclosed in recent SEC filings. The company's communications indicate a directional intent to enter healthcare services and digital health, but the preponderance of current assets remains cash, restricted cash, and short-term instruments.

### Who runs investment decisions at Akso Health Group?

Yilin Wang serves as the Chief Executive Officer and is the primary named executive steering the company's strategic shift toward healthcare. Given the firm's minimal disclosed headcount and lack of a named investment committee, strategic and investment decisions appear to rest with Wang and the board.

### How does Akso Health Group source deal flow?

The firm has not disclosed a sourcing model, partnership network, or pipeline. In the absence of demonstrated deal activity under the Akso Health brand, its sourcing capabilities remain unproven and are not documented in any publicly available investor materials.

### Is Akso Health Group still active in China's peer-to-peer lending sector?

No. Current SEC filings consistently describe the legacy peer-to-peer lending business as discontinued or wound down. The company no longer generates operating revenue from lending activities and maintains no disclosed loan facilitation operations.

## Related profiles

- [Dole plc](https://altss.com/profile/dole-plc)
- [O-I Glass](https://altss.com/profile/o-i-glass-inc-de)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/akso-health-group

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology
